Literature DB >> 16785603

Effects of age, gender, and gonadectomy on neurochemistry and behavior in animal models of Parkinson's disease.

Andrea Tamás1, Andrea Lubics, István Lengvári, Dóra Reglodi.   

Abstract

The effects of aging and gender on the neurochemistry of the dopaminergic system have been studied extensively; however, data on comparative behavioral consequences of lesions of the dopaminergic system in aging and in female animals are limited. This study presents experimental results on the behavioral and morphological outcome in young, aging, and gonadectomized male and female rats in the 6-OHDA model of Parkinson's disease. Both young and aging male animals were more susceptible to 6-OHDA than females: female rats had significantly less dopaminergic cell loss and showed a higher degree of behavioral recovery. Although the dopaminergic cell loss was only slightly more in the aging rats of the same sex, they showed more severe behavioral deficits in both gender groups. Ovariectomy did not significantly influence the dopaminergic cell loss, but behavioral recovery was worse when compared to non-ovariectomized females. In contrast, castrated males had significantly less dopaminergic cell loss than non-castrated males, but the behavioral recovery was not significantly better. The obtained results are discussed in light of the available literature on the age and gender differences in animals models of Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16785603     DOI: 10.1385/ENDO:29:2:275

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  206 in total

1.  Enhanced effects of 6-hydroxydopamine on evoked overflow of striatal dopamine in aged rats.

Authors:  Wayne A Cass; Michael E Harned; Sherry L Bailey
Journal:  Brain Res       Date:  2002-05-31       Impact factor: 3.252

2.  Behavioral and neurochemical dynamics of neurotoxic meso-striatal dopamine lesions.

Authors:  R K Schwarting; J P Huston
Journal:  Neurotoxicology       Date:  1997       Impact factor: 4.294

3.  Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/B1 mice.

Authors:  D E Dluzen; J L McDermott; B Liu
Journal:  Neurotoxicol Teratol       Date:  1996 Sep-Oct       Impact factor: 3.763

4.  Effect of aging on striatal dopamine receptor subtype recovery following N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline blockade and relation to motor function in Wistar rats.

Authors:  J M Henry; J A Joseph; K Kochman; G S Roth
Journal:  Brain Res       Date:  1987-08-25       Impact factor: 3.252

5.  Older dopaminergic neurons do not recover from the effects of MPTP.

Authors:  G A Ricaurte; L E DeLanney; I Irwin; J W Langston
Journal:  Neuropharmacology       Date:  1987-01       Impact factor: 5.250

6.  Effects of female sex steroids on Parkinson's disease in postmenopausal women.

Authors:  E Strijks; J A Kremer; M W Horstink
Journal:  Clin Neuropharmacol       Date:  1999 Mar-Apr       Impact factor: 1.592

7.  Pharmacological correction of CNS functional disorders and parkinsonian syndrome in old animals.

Authors:  T A Voronina; L N Nerobkova; O A Kutepova; D A Gugutcidse
Journal:  Ann Ist Super Sanita       Date:  1990       Impact factor: 1.663

8.  Interactive effects of tamoxifen and estrogen upon the nigrostriatal dopaminergic system.

Authors:  J L McDermott; L I Anderson; D E Dluzen
Journal:  Neuroendocrinology       Date:  1997-09       Impact factor: 4.914

Review 9.  Melatonin in relation to cellular antioxidative defense mechanisms.

Authors:  R J Reiter; R C Carneiro; C S Oh
Journal:  Horm Metab Res       Date:  1997-08       Impact factor: 2.936

10.  Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B.

Authors:  K T Finnegan; I Irwin; L E Delanney; J W Langston
Journal:  J Pharmacol Exp Ther       Date:  1995-05       Impact factor: 4.030

View more
  18 in total

1.  Sex differences in motor behavior in the MPTP mouse model of Parkinson's disease.

Authors:  Eleni Antzoulatos; Michael W Jakowec; Giselle M Petzinger; Ruth I Wood
Journal:  Pharmacol Biochem Behav       Date:  2010-03-27       Impact factor: 3.533

2.  Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease.

Authors:  Kelly Claire Simon; Honglei Chen; Xiang Gao; Michael A Schwarzschild; Alberto Ascherio
Journal:  Mov Disord       Date:  2009-07-15       Impact factor: 10.338

3.  Exacerbation of sensorimotor dysfunction in mice deficient in Atp13a2 and overexpressing human wildtype alpha-synuclein.

Authors:  Emily R Dirr; Osunde R Ekhator; Rachel Blackwood; John G Holden; Eliezer Masliah; Patrick J Schultheis; Sheila M Fleming
Journal:  Behav Brain Res       Date:  2018-02-03       Impact factor: 3.332

4.  Sex differences in skilled movement in response to restraint stress and recovery from stress.

Authors:  Nafisa M Jadavji; Gerlinde A Metz
Journal:  Behav Brain Res       Date:  2008-09-19       Impact factor: 3.332

5.  Young and middle-aged rats exhibit isometric forelimb force control deficits in a model of early-stage Parkinson's disease.

Authors:  Crystal S Bethel-Brown; Jill K Morris; John A Stanford
Journal:  Behav Brain Res       Date:  2011-07-08       Impact factor: 3.332

6.  Castration induces Parkinson disease pathologies in young male mice via inducible nitric-oxide synthase.

Authors:  Saurabh Khasnavis; Anamitra Ghosh; Avik Roy; Kalipada Pahan
Journal:  J Biol Chem       Date:  2013-06-06       Impact factor: 5.157

7.  Androgens exacerbate motor asymmetry in male rats with unilateral 6-hydroxydopamine lesion.

Authors:  Rebecca L Cunningham; Teresa Macheda; Lora Talley Watts; Ethan Poteet; Meharvan Singh; James L Roberts; Andrea Giuffrida
Journal:  Horm Behav       Date:  2011-08-31       Impact factor: 3.587

8.  Changes in the content of estrogen alpha and progesterone receptors during differentiation of mouse embryonic stem cells to dopamine neurons.

Authors:  Néstor F Díaz; Christian Guerra-Arraiza; Néstor E Díaz-Martínez; Patricia Salazar; Anayansi Molina-Hernández; Ignacio Camacho-Arroyo; Ivan Velasco
Journal:  Brain Res Bull       Date:  2007-02-28       Impact factor: 4.077

Review 9.  PACAP deficiency as a model of aging.

Authors:  D Reglodi; T Atlasz; E Szabo; A Jungling; A Tamas; T Juhasz; B D Fulop; A Bardosi
Journal:  Geroscience       Date:  2018-10-22       Impact factor: 7.713

10.  A New Synuclein-Transgenic Mouse Model for Early Parkinson's Reveals Molecular Features of Preclinical Disease.

Authors:  Diana M Hendrickx; Pierre Garcia; Amer Ashrafi; Alessia Sciortino; Kristopher J Schmit; Heike Kollmus; Nathalie Nicot; Tony Kaoma; Laurent Vallar; Manuel Buttini; Enrico Glaab
Journal:  Mol Neurobiol       Date:  2020-09-30       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.